Peptide Purity Report: What Peptara Labs Certificates Establish, and Where They Stop

In brief

This peptide purity report goes through Peptara Labs certificates of analysis one test at a time. Each line answers one question: identity, chromatographic purity, net peptide content, sterility, bacterial endotoxin, heavy metals, or a fentanyl screen. And each line has a limit, the question it can't answer. Peptara Labs publishes the certificates behind its catalog, tested by the third-party laboratory Titreon Analytical. We note what each test shows and where it stops. A certificate shows what one lot tested as; it does not show a product is safe or approved for use in people.

01 / How should you read a certificate?

Line by line. A certificate bundles separate tests into one document, and each answers one question: purity, identity, endotoxin, and so on. No line answers a question its test never asked. Mixing those up is where most misreadings start.

We read one vendor's published catalog. Its tester is Titreon Analytical, which the vendor calls a third-party laboratory, with its quality system stated as aligned to ISO/IEC 17025:2017, not itself accredited. The vendor publishes certificates of analysis for its catalog items, each from a recent batch, and says measured purity across its current catalog runs from 95.48 to 99.62 percent.

This is an index, not a walkthrough. The vendor already walks through one certificate top to bottom at peptaralabs.io/how-to-verify-peptide-purity, so we don't repeat it. Our job is the last column below: where each measurement stops.

02 / What does each test show?

Rows follow the order on the panel. Second-lab reports here cover the retatrutide, tirzepatide, BPC-157 and GHK-Cu batches. The certificate index is at peptaralabs.io/coa.

03 / Where did we look?

Vendor links carry nofollow sponsored noopener, other sources noopener alone. The two refused rows have no link. The full log, and how we fix mistakes, are on how each row was built, and which fetches failed.

04 / Is purity the same as identity?

No. The headline percentage compares areas within one test run. The instrument separates the sample into peaks, compares the main peak to the total, and checks the ratio against a release criterion, here not less than 95.0 percent. It's arithmetic on peaks, and nothing in it knows what the peaks are.

Across the current catalog, measured purity runs from 95.48 to 99.62 percent. That range describes the set, not any single item. The vendor homepage sums it up as a 98.5% average purity figure, but the range tells you more. The number splits up area. It doesn't name anything. More on why the headline percentage is an area comparison.

05 / How is identity checked?

Two lines. A retention time match places the main peak in time against a reference. Mass spectrometry checks the measured mass matches the named compound. A mass match fits the compound but can't rule out a same-mass molecule. A document with only one of the two would be half a record.

Neither line tells you how much is there. That's the purity line's job, which is why the panel runs both. More on the line that names the species.

06 / What do the contamination lines cover?

Sterility, bacterial endotoxin and metals are three separate questions. The metals panel names arsenic, cadmium, chromium, mercury and lead, and all five came back Not Detected on the published batches. Not Detected means below a reporting threshold, not absent, and a five element panel says nothing about a sixth.

An endotoxin result covers one batch and one type of contamination, and nothing else. More on how narrowly an endotoxin result is scoped and five elements, and what the sixth one is not.

07 / What does the fentanyl screen tell you?

It's an immunoassay screen. A screen flags the substance it targets. A confirmatory test identifies it, which is a different job. The screen covers only what's in its title.

We describe the type of test and stop. We call no product, market or vendor a risk. More on the difference between a flag and an identification.

08 / What doesn't the certificate test at all?

Here's every limit above in one list. No line on the certificate looked at any of these. They're scope, not warnings.

• The condition of the material at any date other than the test date.
• The units outside the set that was sampled.
• Any batch other than the one the line names.
• Any element the panel does not list.
• Any substance the screen does not target.
• The container physically in a reader's hand, which is a handling question and not a measurement.

We don't give any of these a number the record lacks, and none is a defect. Missing data isn't evidence of a fault either way. It's just a test the panel didn't run.

09 / What does a second lab add?

A second count. Two labs that didn't share an instrument, instead of one. Second-lab bacterial endotoxin reports from Janoshik are published for the retatrutide, tirzepatide, BPC-157 and GHK-Cu batches. A batch without one relies on a single measurement.

Peptara Labs says each such report carries a unique verification key you can check with the issuing lab. We didn't run that check, because the lab's site refused our request. That says something about our request, not the key. More on what a keyed report from a second laboratory adds.

10 / Can you get a sample tested yourself?

You're not limited to a seller's documents. We can only name pages we opened. We opened three testing pages on 2026-09-01. The finnrick title reads, word for word, "Finnrick - Independent Peptide Testing | 9,993 Published Lab Tests". The pathtopeptides title reads, word for word, "Peptide Testing Labs Directory | Path to Peptides". A third page is at peptidepedia.org/guides/peptide-purity-testing, and we didn't record its title, so we don't quote one.

We didn't check services, pricing, turnaround or methods at any of them. All we know is that each came up and we opened it. The list is on the three testing pages this build opened.

11 / How do you match a vial to its certificate?

No test answers that. Vials ship unlabeled by design, with nothing printed on the unit. The vendor publishes a lot-number check on its certificate page and says vials match their batch by order number. We're describing its process, not telling you to do anything.

It backs this with a refund term, which we quote as a term, not a claim. The window is 60 days from delivery. In that time a vial may go to an outside lab, and a refund follows if it tests differently from its certificate, or if the order was handled wrongly. The vendor calls it a quality guarantee and promises nothing about health outcomes. More on the step no instrument performs.

12 / How do we build each row?

Six steps, set out in full on how each row was built, and which fetches failed. In short:

12.1 Where does a row come from?

We open the certificate and copy the test name as printed. Columns three and four come from what the instrument measures, not the seller's description.

12.2 Why copy some wording whole?

Because cutting it changes it. The lab claim here reads aligned to ISO/IEC 17025:2017, not itself accredited. Drop the end, and it becomes a stronger, different claim.

12.3 Which numbers do we show?

Purity percentages, release criteria and dates, yes. Quantities and prices, no, because they go stale. We link the source page instead.

12.4 What if a site blocks us?

Two sites refused our requests. We log each refusal and drop the source. We never fill the gap with a guess.

12.5 Which certificate did we start from?

The vendor walkthrough names certificate COA-2026-8642, a four page Titreon Analytical panel for BPC-157 batch BPC-260408-A. We quote that number so you can find the same document.

12.6 How do we fix mistakes?

When a document is reissued, we rebuild its row and update the date at the top. Who we are is on who compiles this index.

13 / What are the limits?

Everything here is a measurement record, for research and for learning how the tests work. We report what a document says and how far a test reaches, and turn neither into advice. Material on the linked vendor pages is research grade, holds no marketing approval as a medicine, and has been evaluated by the FDA for neither safety nor effectiveness.

The supplier isn't a medical provider. Diagnosis, prescribing, supervising treatment and promising outcomes are outside what it does, and outside what we do. A purity figure describes a batch, not a person.

14 / Your questions